Totally agree here the latest safety report for CHF trial recommended continuing the trial.No safety concerns after 27 months into this trial and also all of the other current trials underway.The term used (very high risk) is an over exageration in the area of safety and even in relation to current advanced phase 3 trials!
- Forums
- ASX - By Stock
- Predictions do come true
Totally agree here the latest safety report for CHF trial...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 75212 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 1.185 |
4 | 69624 | 1.180 |
3 | 122218 | 1.175 |
3 | 86297 | 1.170 |
2 | 52098 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 75212 | 5 |
1.195 | 71199 | 8 |
1.200 | 793756 | 45 |
1.205 | 83717 | 4 |
1.210 | 193114 | 8 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
MSB (ASX) Chart |